) will establish Schering-Plough  Produtos Farmaceuticos Limitada in Sao Paulo, Brazil, to market its core products.  The company will also restructure its agreement (originally formed in 1991)  with Brazil-based drug manufacturer Mantefarma, now to be known as Mantecorp,  in an effort to increase Schering’s presence in Latin America. Schering-Plough  Produtos Farmaceuticos Limitada will commercialize specialty care products,  including hepatitis C treatment PegIntron (peginterferon alfa-2b) and cancer-fighting  drugs Temodal (temozolomide) and Caelyx (pegylated liposomal doxorubicin HCI).

News

Schering-Plough (Kenilworth, NJ, www.sch-plough.com) will establish Schering-Plough Produtos Farmaceuticos Limitada in Sao Paulo, Brazil, to market its core products.